Trial intelligence / Profile preview

Concomitant Administration of Trumenba, Menactra, and Adacel in Adolescents

NCT01461980Phase 2Completed

Sponsor
Pfizer
Start
Sep 2011
Primary completion
May 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of meningococcal group B vaccine in Meningococcal Disease Group B, sponsored by Pfizer. Started Sep 2011; status: completed.

02

Drugs

meningococcal group B vaccine
03

Conditions

Meningococcal Disease Group B

Beyond the preview

Go deeper on NCT01461980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01461980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call